The aim of this study was to compare the accuracy and clinical utility of qPCR and ddPCR applied at diagnosis and in MRD monitoring of JAK2 V617F-positive patients with myeloproliferative neoplasms. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.